Centene Corp | CNC | Long at $35.00Centene Corp NYSE:CNC is a healthcare enterprise providing programs and services to under-insured and uninsured families, commercial organizations, and military families in the U.S. through Medicaid, Medicare, Commercial, and other segments. The stock dropped almost 40% this morning due to recent challenges, such as a $1.8B reduction in 2025 risk adjustment revenue and rising Medicaid costs (leading to withdrawal of 2025 earnings guidance). However, the company has a book value near $56, debt-to-equity of 0.7x (healthy), a current P/E of 5x, and a forward P/E of 9x.
It may be a few years before this stock recovers. But the price has entered my "crash" simple moving average area (currently between $32 and $36) and there is a price gap on the daily chart between $32 and $33 that will likely be closed before a move higher. Long-term, and potentially a new political administration, new life may enter this stock once again as the baby boom generation requires more healthcare services. But holding is not for the faint of heart...
Thus, at $35.00, NYSE:CNC is in a personal buy zone with a likely continued dip into the low $30s or high $20s before a slow move higher (where I will be accumulating more shares). Full disclosure: I am also a position holder in the $60s and cost averaging down.
Targets into 2028:
$45.00 (+28.6%)
$54.00 (+54.3%)
Healthcareproviders
BFLY Should Hold SupportBFLY Current Price $12.75 Price Target $20
This company is a fairly valued (5x PE) innovative healthcare company. Butterfly Networks is cutting the cost of ultrasounds by 90% with their handheld device, the new ultrasound platform uses a semiconductor rather than a crystal based sound wave. They are targeting emerging markets with this amazing cost cutting innovation. It hasn’t been a better time to buy BFLY in quite some time as BFLY is now trading on crucial support around $12.50. I think we hold this support line and trade up to the top line of resistance around $15 within the next couple months then we should move up to $20 in the coming months.
Healthcare Critical LevelTechnical Analysis
The 200ema has been tested several times, and has worked very well as a mid-term support level.
Risk reward ratio is easy to set-up with a 3:1 ratio approximately.
Sector & Industry Analysis
It is important to note that the industries inside the sector have different performance, which has been very useful to analyze what the market thinks of the risk of healthcare with the election coming up.
The following list is the Healthcare Industries with a 6-month performance % move, as well as a some good ETF to follow/trade:
Healthcare Technology --> +56% // have not found appropriate ETF.
Biotechnology --> +21% // XBI (smaller biotech), IBB (large-cap biotech), ARKG (genomics)
Healthcare Equipment --> +19% // IHI
Healthcare Providers --> +5.51% // IHF
Pharmaceuticals --> -1.3% // IHE